Literature DB >> 8416324

Outcome of patients hospitalized for complications after outpatient liver biopsy.

C H Janes1, K D Lindor.   

Abstract

OBJECTIVE: To determine the safety of outpatient liver biopsies by analyzing the outcome of patients hospitalized for complications.
DESIGN: Retrospective review.
SETTING: Large clinic referral center. PATIENTS: All patients admitted after outpatient liver biopsy at the Mayo Clinic from 1 April 1989 to 1 April 1991.
RESULTS: During this period, 405 outpatients underwent biopsy. Of the 405 patients, 13 (3.2%) were admitted with complications after biopsy. Five patients (38%) were admitted with persistent localized pain, five (38%) with orthostatic hypotension, one (8%) with both pain and hypotension, one (8%) with peritoneal signs, and one (8%) with lightheadedness but no orthostatic changes. All complications were noted within 3 hours after the biopsy. Bleeding, potentially the most serious complication, was radiographically defined in 5 of the 13 patients (38%) admitted. Only two patients, however, required blood transfusions. No patient required invasive management such as surgery or chest tube placement. The average length of the hospital stay was 1.5 days.
CONCLUSION: Complications after outpatient liver biopsy occur early and rarely require invasive management. Outpatient liver biopsy is safe when done on carefully selected patients in a setting that provides close observation for at least 3 hours after liver biopsy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416324     DOI: 10.7326/0003-4819-118-2-199301150-00003

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  67 in total

1.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey.

Authors:  W Mayoral; J H Lewis
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology.

Authors:  A Grant; J Neuberger
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 3.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  Predictors of pain medication use after percutaneous liver biopsy.

Authors:  Thomas R Riley
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

5.  Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence.

Authors:  M Deng; F Zhao; J Yuan; A T Ahuja; Y-X J Wang
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

6.  Liver biopsy in a district general hospital: changes over two decades.

Authors:  Wing-Kin Syn; Caroline Bruckner-Holt; Adam Farmer; Sarah Howdle; Jeffrey Bateman
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 7.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

8.  The effect of processing on liver biopsy core size.

Authors:  Thomas R Riley; Francesca M Ruggiero
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

9.  A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.

Authors:  Chong Hyun Suh; Kyung Won Kim; Seong Ho Park; Sangjin Shin; Jeonghoon Ahn; Junhee Pyo; Atul B Shinagare; Katherine M Krajewski; Nikhil H Ramaiya
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

10.  Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection.

Authors:  Fadi Antaki; M Margaret French; Dilip K Moonka; Stuart C Gordon
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.